179 related articles for article (PubMed ID: 8679512)
1. Effect of miglitol and acarbose on starch digestion, daily plasma glucose profiles and cataract formation.
Madar Z; Hazan A
J Basic Clin Physiol Pharmacol; 1993; 4(1-2):69-81. PubMed ID: 8679512
[TBL] [Abstract][Full Text] [Related]
2. The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?
Joubert PH; Venter HL; Foukaridis GN
Br J Clin Pharmacol; 1990 Sep; 30(3):391-6. PubMed ID: 2223417
[TBL] [Abstract][Full Text] [Related]
3. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
Madar Z
J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus.
Reuser AJ; Wisselaar HA
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():19-24. PubMed ID: 8001622
[TBL] [Abstract][Full Text] [Related]
5. Miglitol, a new alpha-glucosidase inhibitor.
Sels JP; Huijberts MS; Wolffenbuttel BH
Expert Opin Pharmacother; 1999 Nov; 1(1):149-56. PubMed ID: 11249557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of alpha-glucosidase inhibition.
Bischoff H
Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-inhibitors on blood glucose and insulin levels.
Laube H; Federlin K; Hillebrand I
Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
[No Abstract] [Full Text] [Related]
8. Beneficial effects of acarbose on daily plasma glucose profile and cataract development in sand rats.
Madar Z; Hazan A; Pollack A
Eye (Lond); 1994; 8 ( Pt 3)():353-6. PubMed ID: 7958047
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.
Ladas SD; Frydas A; Papadopoulos A; Raptis SA
Gut; 1992 Sep; 33(9):1246-8. PubMed ID: 1427379
[TBL] [Abstract][Full Text] [Related]
10. Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase.
Joubert PH; Foukaridis GN; Bopape ML
Eur J Clin Pharmacol; 1987; 31(6):723-4. PubMed ID: 3549325
[TBL] [Abstract][Full Text] [Related]
11. Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.
Heinz G; Komjati M; Korn A; Waldhäusl W
Eur J Clin Pharmacol; 1989; 37(1):33-6. PubMed ID: 2687007
[TBL] [Abstract][Full Text] [Related]
12. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
Russell JC; Graham SE; Dolphin PJ
Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
[TBL] [Abstract][Full Text] [Related]
13. [Reducing postprandial glucose levels. Glucosidase antagonists].
Neye H
Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
[No Abstract] [Full Text] [Related]
14. [Inhibitors of alpha-glucosidase].
Toeller M
Journ Annu Diabetol Hotel Dieu; 1991; ():203-12. PubMed ID: 1886331
[No Abstract] [Full Text] [Related]
15. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?
Scheen AJ
Drugs; 2003; 63(10):933-51. PubMed ID: 12699398
[TBL] [Abstract][Full Text] [Related]
16. Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes.
Tattersall R
Diabet Med; 1993 Oct; 10(8):688-93. PubMed ID: 8261749
[No Abstract] [Full Text] [Related]
17. Postprandial glycemic control, hormonal effects and carbohydrate malabsorption during long-term administration of the alpha-glucosidase inhibitor miglitol.
Lembcke B; Diederich M; Fölsch UR; Creutzfeldt W
Digestion; 1990; 47(1):47-55. PubMed ID: 2292349
[TBL] [Abstract][Full Text] [Related]
18. Alpha-glucosidase inhibitors for type 2 diabetes mellitus.
Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycemic and hormonal responses after repetitive sucrose and starch loads by different doses of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in man.
Lembcke B; Fölsch UR; Gatzemeier W; Ebert R; Siegel E; Creutzfeldt W
Pharmacology; 1991; 43(6):318-28. PubMed ID: 1784628
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal storage of glycogen as a sequel of alpha-glucosidase inhibition by the absorbed deoxynojirimycin derivative emiglitate (BAYo1248). A drug-induced pattern of hepatic glycogen storage mimicking Pompe's disease (glycogenosis type II).
Lembcke B; Lamberts R; Wöhler J; Creutzfeldt W
Res Exp Med (Berl); 1991; 191(6):389-404. PubMed ID: 1775731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
